Literature DB >> 1362779

Systemic lupus international collaborative clinics: development of a damage index in systemic lupus erythematosus.

D Gladman1, E Ginzler, C Goldsmith, P Fortin, M Liang, M Urowitz, P Bacon, S Bombardieri, J Hanly, E Hay.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1362779

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  23 in total

1.  Identifying Differences in Risk Factors for Depression and Anxiety in Pediatric Chronic Disease: A Matched Cross-Sectional Study of Youth with Lupus/Mixed Connective Tissue Disease and Their Peers with Diabetes.

Authors:  Andrea Knight; Pamela Weiss; Knashawn Morales; Marsha Gerdes; Melissa Rearson; Michelle Vickery; Ron Keren
Journal:  J Pediatr       Date:  2015-08-25       Impact factor: 4.406

2.  Anti-NR2 antibodies, blood-brain barrier, and cognitive dysfunction.

Authors:  Gaurav Gulati; Philip H Iffland; Damir Janigro; Bin Zhang; Michael E Luggen
Journal:  Clin Rheumatol       Date:  2016-06-29       Impact factor: 2.980

3.  Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases.

Authors:  Myoung-Hee Kim; Young-Shin Cho; Wan-Sik Uhm; Sehyun Kim; Sang-Cheol Bae
Journal:  Qual Life Res       Date:  2005-06       Impact factor: 4.147

4.  [Lupus in Germany: analysis within the German lupus self-help organization (LULA)].

Authors:  R Fischer-Betz; E Wessel; J Richter; B Winkler-Rohlfing; R Willers; M Schneider
Journal:  Z Rheumatol       Date:  2005-03       Impact factor: 1.372

5.  Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus.

Authors:  Tünde Tarr; Gábor Papp; Nikolett Nagy; Edina Cserép; Margit Zeher
Journal:  Clin Rheumatol       Date:  2016-11-26       Impact factor: 2.980

6.  Development and initial validation of a self-assessed lupus organ damage instrument.

Authors:  Karen H Costenbader; Munther Khamashta; Silvia Ruiz-Garcia; Maria Teresa Perez-Rodriguez; Michelle Petri; Jennifer Elliott; Susan Manzi; Elizabeth W Karlson; Tabitha Turner-Stokes; Bonnie Bermas; Jonathan Coblyn; Elena Massarotti; Peter Schur; Patricia Fraser; Iris Navarro; John G Hanly; Timothy S Shaver; Robert S Katz; Eliza Chakravarty; Paul R Fortin; Martha L Sanchez; Jigna Liu; Kaleb Michaud; Graciela S Alarcón; Frederick Wolfe
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-04       Impact factor: 4.794

7.  Medical costs incurred by organ damage caused by active disease, comorbidities and side effect of treatments in systemic lupus erythematosus patients: a Taiwan nationwide population-based study.

Authors:  Y M Chiu; M T Chuang; H C Lang
Journal:  Rheumatol Int       Date:  2016-08-17       Impact factor: 2.631

8.  Tuberculosis and systemic lupus erythematosus: a case-control study in Mexico City.

Authors:  Pedro Torres-González; Juanita Romero-Díaz; Miguel Enrique Cervera-Hernández; Mario Ocampo-Torres; Luis Gerardo Chaires-Garza; Ernesto Alejandro Lastiri-González; Yemil Atisha-Fregoso; Miriam Bobadilla-Del-Valle; Alfredo Ponce-de-León; José Sifuentes-Osornio
Journal:  Clin Rheumatol       Date:  2018-04-20       Impact factor: 2.980

9.  The SLICC inception cohort for atherosclerosis.

Authors:  Murray B Urowitz; Dafna D Gladman
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

10.  Clinical features and long-term outcomes of systemic lupus erythematosus: comparative data of childhood, adult and late-onset disease in a national register.

Authors:  S Sousa; M J Gonçalves; L S Inês; G Eugénio; D Jesus; S Fernandes; G Terroso; V C Romão; M Cerqueira; A Raposo; M Couto; P Nero; G Sequeira; T Nóvoa; J A Melo Gomes; J Canas da Silva; L Costa; C Macieira; C Silva; J A P Silva; H Canhão; M J Santos
Journal:  Rheumatol Int       Date:  2016-03-15       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.